BOSTON SCIENTIFIC CORPORATION — Revenue by Fiscal Year

19 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/6c5f4f3c-d3ac-4ce0-971e-55391f3422c5/serie/revenue

Fiscal yearRevenuePeriodEvidence
FY 2025$20.1B2025-01-01 – 2025-12-31evidence 0000885725-26-000010
FY 2024$16.7B2024-01-01 – 2024-12-31evidence 0000885725-25-000011
FY 2023$14.2B2023-01-01 – 2023-12-31evidence 0000885725-24-000017
FY 2022$12.7B2022-01-01 – 2022-12-31evidence 0000885725-23-000008
FY 2021$11.9B2021-01-01 – 2021-12-31evidence 0000885725-22-000006
FY 2020$9.9B2020-01-01 – 2020-12-31evidence 0000885725-21-000008
FY 2019$10.7B2019-01-01 – 2019-12-31evidence 0000885725-20-000012
FY 2018$9.8B2018-01-01 – 2018-12-31evidence 0000885725-19-000011
FY 2017$9.0B2017-01-01 – 2017-12-31evidence 0000885725-19-000011
FY 2016$8.4B2016-01-01 – 2016-12-31evidence 0000885725-19-000011
FY 2015$7.5B2015-01-01 – 2015-12-31evidence 0000885725-16-000028
FY 2014$7.4B2014-01-01 – 2014-12-31evidence 0000885725-15-000006
FY 2013$7.1B2013-01-01 – 2013-12-31evidence 0000885725-14-000005
FY 2012$7.2B2012-01-01 – 2012-12-31evidence 0000885725-13-000007
FY 2011$7.6B2011-01-01 – 2011-12-31evidence 0000885725-12-000006
FY 2010$7.8B2010-01-01 – 2010-12-31evidence 0000950123-11-015112
FY 2009$8.2B2009-01-01 – 2009-12-31evidence 0000950123-10-017254
FY 2008$8.1B2008-01-01 – 2008-12-31evidence 0000950123-10-017254
FY 2007$8.4B2007-01-01 – 2007-12-31evidence 0000950123-10-017254
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

BOSTON SCIENTIFIC CORPORATION — all facts · Operating Income